Johnson Matthey (JMPLY) Upgraded at Zacks Investment Research

Zacks Investment Research upgraded shares of Johnson Matthey (OTCMKTS:JMPLY) from a hold rating to a buy rating in a report issued on Wednesday morning, reports. The brokerage currently has $94.00 target price on the basic materials company’s stock.

According to Zacks, “Johnson Matthey Plc is a speciality chemicals company focused on its core skills in catalysis, precious metals, fine chemicals and process technology. Its principal activities comprise manufacture of autocatalysts, heavy duty diesel catalysts and pollution control systems, catalysts and components for fuel cells, catalysts and technologies for chemical processes, fine chemicals, chemical catalysts and active pharmaceutical ingredients. The Company also engages in the marketing, refining, and fabrication of precious metals. Its environmental technologies include emission control technologies, process technologies and fuel cells. Its precious metals products include platinum, noble metals, catalysts, chemicals and refining and colour technologies. Its fine chemicals include macfarlan smith, pharmaceutical materials and services and research chemicals. Johnson Matthey Plc is headquartered in London, U.K. “

A number of other equities research analysts have also recently issued reports on the company. HSBC upgraded Johnson Matthey from a hold rating to a buy rating in a research note on Thursday, December 13th. ValuEngine raised Johnson Matthey from a sell rating to a hold rating in a report on Wednesday, January 2nd. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. The company has a consensus rating of Buy and an average target price of $94.00.

JMPLY stock opened at $86.11 on Wednesday. The company has a market capitalization of $8.33 billion, a price-to-earnings ratio of 15.60, a P/E/G ratio of 1.19 and a beta of 1.49. Johnson Matthey has a twelve month low of $67.00 and a twelve month high of $102.55.

Johnson Matthey Company Profile

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.

Featured Article: What are the FAANG Stocks?

Get a free copy of the Zacks research report on Johnson Matthey (JMPLY)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with's FREE daily email newsletter.